National Jewish Health
Clinical trials sponsored by National Jewish Health, explained in plain language.
-
Could a DNA-Busting enzyme ease tough asthma?
Symptom relief CompletedThis small pilot study tested whether inhaling a drug called rh-DNase for 4 weeks could help people with neutrophilic asthma, a type that often doesn't respond well to standard treatments. Nineteen adults with confirmed asthma and signs of airway inflammation took part. The goal …
Phase: PHASE1, PHASE2 • Sponsor: National Jewish Health • Aim: Symptom relief
Last updated May 17, 2026 10:08 UTC
-
Gene sleuths hunt superbugs in cystic fibrosis lungs
Knowledge-focused CompletedThis study looked at sputum (mucus) from 83 adults with cystic fibrosis who were hospitalized for sudden lung worsening (called a pulmonary exacerbation). Researchers used genetic testing to find which antibiotic-resistant bacteria were present and compared those results to how w…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated May 17, 2026 10:10 UTC
-
Cystic fibrosis mystery: why do some lungs never bounce back?
Knowledge-focused CompletedThis study looked at 29 adults with cystic fibrosis who were hospitalized for a lung infection. Researchers collected blood, sputum, and urine to study how infection and inflammation affect recovery of lung function. The goal is to find better ways to personalize treatment and im…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated May 17, 2026 10:09 UTC
-
New study tracks COVID-19 vaccine durability in chronically ill patients
Knowledge-focused CompletedThis study followed 360 adults and children with chronic medical conditions to see how long their immune protection lasts after COVID-19 vaccination. Researchers measured antibody, T cell, and B cell responses before vaccination and every 3 months for 18 months. The goal is to un…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated May 17, 2026 10:05 UTC
-
New study tracks CF patients on modern drugs to uncover hidden disease patterns
Knowledge-focused CompletedThis study followed 58 adults with cystic fibrosis (CF) who were starting or switching to a new CFTR modulator medication as part of their regular care. Researchers collected blood, sputum, urine, and quality-of-life surveys before and after treatment to see how inflammation, lun…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated May 17, 2026 10:03 UTC